We know CBT-I works, now what?

Alexandria Muench; Ivan Vargas; Michael A Grandner; Jason G Ellis; Donn Posner; Célyne H Bastien; Sean Pa Drummond; Michael L Perlis

doi:10.12703/r/11-4

We know CBT-I works, now what?

Fac Rev. 2022 Feb 1:11:4. doi: 10.12703/r/11-4. eCollection 2022.

Authors

Alexandria Muench^{1

2}, Ivan Vargas³, Michael A Grandner⁴, Jason G Ellis⁵, Donn Posner⁶, Célyne H Bastien⁷, Sean Pa Drummond⁸, Michael L Perlis^{1

2}

Affiliations

¹ Behavioral Sleep Medicine Program, Department of Psychiatry, University of Pennsylvania, PA, USA.
² Chronobiology and Sleep Institute, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Department of Psychological Sciences, University of Arkansas, Fayetteville, AR, USA.
⁴ Department of Psychiatry, University of Arizona, AZ, USA.
⁵ Northumbria Centre for Sleep Research, Northumbria University, UK.
⁶ Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, USA.
⁷ School of Psychology, Laval University, Pavillon Félix-Antoine-Savard, Québec, Canada.
⁸ Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Victoria, Australia.

PMID: 35156100
PMCID: PMC8808745
DOI: 10.12703/r/11-4

Abstract

Cognitive behavioral therapy for insomnia (CBT-I) has been shown to be efficacious and now is considered the first-line treatment for insomnia for both uncomplicated insomnia and insomnia that occurs comorbidly with other chronic disorders (comorbid insomnia). The purposes of this review are to provide a comprehensive summary of the efficacy data (for example, efficacy overall and by clinical and demographic considerations and by CBT-I formulation) and to discuss the future of CBT-I (for example, what next steps should be taken in terms of research, dissemination, implementation, and practice).

Keywords: CBT-I; Efficacy; Future Directions; Insomnia.

Publication types

Review

Abstract

Publication types

Grants and funding